https://www.businesswire.com/news/home/20230808554123/en/AgNovos-Bioscience-Announces-150th-Patient-Enrolled-in-RESTORE-Randomized-Controlled-Trial
AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE Randomized, Controlled Trial
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
bioscienceannouncespatient